MATTHEW J RESCHLY M.D.
NPI 1417949777
Dermatology in Lawrenceville, GA

Active since August 22, 2005PECOS EnrolledCLIA 11D2299018 · Waiver
2000 RIVERSIDE PKWY STE 100, LAWRENCEVILLE, GA 30043(470) 273-7233 Get Directions Write a Review

NPPES record last updated: March 27, 2023. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Mar 27, 2023, Oct 2, 2015 (2 updates tracked since 2015).

About Matthew J Reschly M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

MATTHEW J RESCHLY M.D. (NPI 1417949777) is an individual dermatology provider in Lawrenceville, Georgia, licensed in Georgia (053393) and active in the NPI registry since August 2005. He is enrolled in Medicare PECOS, holds a CLIA Waiver certificate valid through February 12, 2028, and maintains a secondary practice location in Duluth.

NPPES Registry Identity

NPI1417949777
Entity TypeIndividualMale
Primary Taxonomy207N00000X
Provider Legal NameMATTHEW J RESCHLYCredential: M.D.
Location Address2000 RIVERSIDE PKWY STE 100Lawrenceville, GA 30043-5926
Mailing Address268 Rumson Rd NeAtlanta, GA 30305-3114 · (404) 323-4260
Sole ProprietorNo
Medical School CMSUniversity Of Florida College Of MedicineGraduated 1998
Enumeration DateAugust 22, 2005
Last NPPES UpdateMarch 27, 20232 updates tracked since enumeration
NPPES CertifiedMarch 27, 2023
NPI 1417949777 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 3

Primary SpecialtyDermatologyAllopathic & Osteopathic Physicians
Taxonomy Code207N00000X
License Licensed in GA · 053393
Definition
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Also ListedDermatology · DermatopathologyTaxonomy 207ND0900X · License 053393 (GA)
Also ListedDermatology · Procedural DermatologyTaxonomy 207NS0135X · License 053393 (GA)
2000 RIVERSIDE PKWY STE 100, Lawrenceville, GA 30043

Secondary Practice Location 1

Location 13850 Pleasant Hill RdDuluth, GA 30096-4807 · Phone (770) 814-8222 ext. 226 · Fax (678) 205-5111

Other Identifiers 6

Medicaid749377509CGA
Medicaid749377509EGA
Medicaid749377509DGA
OtherP00119685GA · Rr Medicare
Other703213GA · Bcbs
Medicaid749377509AGA

Accepted Insurance

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare (PECOS)

Matthew J Reschly M.d. is registered in the CMS Provider Enrollment, Chain and Ownership System (PECOS).

PECOS PAC ID2062541626
PECOS Enrollment IDI20100520000478
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

CLIA Laboratory Certificates CMS CLIA

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Waiver 11D2299018

Matthew J Reschly MD PC · Lawrenceville, GA
Active · expires Feb 12, 2028
CLIA Number11D2299018
Laboratory TypePhysician Office
Certificate Effective DateFebruary 13, 2026
Certificate Expiration DateFebruary 12, 2028
Laboratory DirectorMatthew J. Reschly
Laboratory Phone(678) 535-0067
Laboratory LocationMatthew J Reschly MD PC2000 Riverside Parkway, Suite 100, Lawrenceville, GA 30043
CLIA data matches this NPI record on: Address
This certificate is issued to a laboratory to perform only waived tests.

Areas of Expertise CMS Part B claims 20

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more 99213
This is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
498 services292 patients
Destruction of precancer skin growth, 2-14 growths 17003
This procedure involves removing 2-14 precancerous skin growths. The growths are treated to prevent them from potentially developing into skin cancer. The process is safe, with minimal discomfort, and promotes healthier skin.
432 services96 patients
Biopsy of related skin growth, first growth 11102
A biopsy of a skin growth involves taking a small sample of the growth to examine it under a microscope. This helps determine if the growth is harmful. The procedure is typically quick, with minimal discomfort. It's a crucial step in ensuring your skin's health.
262 services205 patients
Destruction of precancer skin growth, 1 growth 17000
"Destruction of precancer skin growth" is a procedure that eliminates a single precancerous skin growth. This is done to prevent it from developing into skin cancer. The growth may be removed using various methods such as cryotherapy (freezing), laser therapy, or topical medications.
189 services149 patients
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more 99203
This service involves an initial office or outpatient visit for a new patient. The healthcare professional will spend 30-44 minutes understanding your health history, current issues, and discussing possible treatment plans. It's a comprehensive evaluation to start your healthcare journey.
153 services153 patients
Destruction of skin growth, 1-14 growths 17110
"Destruction of skin growth" refers to a procedure where 1-14 abnormal skin growths are removed. This is done using methods such as freezing, burning, or laser therapy. It helps prevent the growth from causing discomfort or turning into a more serious condition.
104 services89 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 30043 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$88.06 typical visit price
range $56.84 – $172.43
Typical copayment $22.01 (range $14.21 – $43.10)
Most-billed visit code 99203
Established Patient
$70.85 typical visit price
range $18.22 – $140.40
Typical copayment $17.71 (range $4.55 – $35.10)
Most-billed visit code 99213
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

Reported Quality Measures

Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
37%12,145 patients1/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
100%5,261 patients5/55-star benchmark: 100%
Health Information Exchange
The MIPS eligible clinician that transitions or refers their patient to another setting of care or health care clinician (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving health care clinician for…
44%192 patients2/55-star benchmark: 98%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
18%3,793 patients1/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
99%11,832 patients4/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
5%2,003 patients1/55-star benchmark: 95%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
23%137 patients1/55-star benchmark: 100%
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol user
17%2,907 patients1/55-star benchmark: 100%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
99%11,832 patients4/55-star benchmark: 100%
Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
Percentage of psoriasis vulgaris patients receiving oral systemic or biologic therapy who meet minimal physician-or patient- reported disease activity levels.
21%42 patients
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier
Percentage of patients whose providers are ensuring active tuberculosis prevention either through yearly negative standard tuberculosis screening tests or are reviewing the patient's history to determine if they have had appropriate management for a recent or…
100%54 patients
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
0%11,832 patients1/55-star benchmark: 79%
Tobacco Use and Help with Quitting Among Adolescents
The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user
96%1,876 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 2

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Dermatology
2000 RIVERSIDE PKWY STE 100
LAWRENCEVILLE, GA 30043
Dermatology (Procedural Dermatology)
2000 RIVERSIDE PKWY STE 100
LAWRENCEVILLE, GA 30043

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Matthew Reschly's NPI number?

The NPI number for Matthew Reschly is 1417949777. It was assigned to this individual provider in the NPPES registry on August 22, 2005.

Where is Matthew Reschly located?

Matthew Reschly practices at 2000 Riverside Pkwy Ste 100, Lawrenceville, GA 30043. The listed phone number is (470) 273-7233.

What is Matthew Reschly's specialty?

The primary specialty registered for this NPI is Dermatology with taxonomy code 207N00000X.

Is Matthew Reschly enrolled in Medicare?

Yes. Matthew Reschly is registered in the Medicare PECOS enrollment system.

Does Matthew Reschly hold a CLIA laboratory certificate?

Yes. A Certificate of Waiver (number 11D2299018) is associated with this NPI, valid through February 12, 2028. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.

What insurance does Matthew Reschly accept?

Health plans from Alliant Health Plans, Inc. list Matthew Reschly as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Matthew Reschly was last updated on March 27, 2023. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 3 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.